These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37157933)

  • 1. Use of hospital care among Dutch diabetes patients.
    de Vries SAG; Bak JCG; Stangenberger VA; Wouters MWJM; Nieuwdorp M; Sas TCJ; Verheugt CL
    Diabetes Obes Metab; 2023 Aug; 25(8):2268-2278. PubMed ID: 37157933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does size matter? Hospital volume and resource use in paediatric diabetes care.
    de Vries SAG; Bak JCG; Mul D; Wouters MWJM; Nieuwdorp M; Verheugt CL; Sas TCJ
    Diabet Med; 2024 May; 41(5):e15260. PubMed ID: 38018287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare expenditure and technology use in pediatric diabetes care.
    de Vries SAG; Bak JCG; Verheugt CL; Stangenberger VA; Mul D; Wouters MWJM; Nieuwdorp M; Sas TCJ
    BMC Endocr Disord; 2023 Apr; 23(1):72. PubMed ID: 37029362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare reimbursement costs of children with type 1 diabetes in the Netherlands, a observational nationwide study (Young Dudes-4).
    Spaans EAJM; van Dijk PR; Groenier KH; Brand PLP; Kleefstra N; Bilo HJG
    BMC Endocr Disord; 2018 Aug; 18(1):57. PubMed ID: 30119628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital treatment costs associated with incident complications in patients with type 2 diabetes-real-world study based on electronic patient information systems.
    Sund R; Peltonen T; Lehtimäki AV; Martikainen J
    BMC Health Serv Res; 2022 Apr; 22(1):469. PubMed ID: 35397604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort.
    Chen HL; Hsu WW; Hsiao FY
    J Diabetes Complications; 2015; 29(4):523-8. PubMed ID: 25770886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up.
    Chen HY; Kuo S; Su PF; Wu JS; Ou HT
    Diabetes Care; 2020 Aug; 43(8):1732-1740. PubMed ID: 32444454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus.
    Sicras-Mainar A; Navarro-Artieda R; Morano R; Ruíz L
    Endocrinol Nutr; 2016 Dec; 63(10):527-535. PubMed ID: 27744013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS).
    Feldman DI; Valero-Elizondo J; Salami JA; Rana JS; Ogunmoroti O; Osondu CU; Spatz ES; Virani SS; Blankstein R; Blaha MJ; Veledar E; Nasir K
    Atherosclerosis; 2017 Mar; 258():79-83. PubMed ID: 28214425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
    Salman RA; AlSayyad AS; Ludwig C
    BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel.
    Melzer Cohen C; Hallén N; Chodick G; Bourvine L; Waner T; Karasik A
    Value Health Reg Issues; 2020 Sep; 22():83-92. PubMed ID: 32798839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates.
    Al-Maskari F; El-Sadig M; Nagelkerke N
    BMC Public Health; 2010 Nov; 10():679. PubMed ID: 21059202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases.
    Scalone L; Cesana G; Furneri G; Ciampichini R; Beck-Peccoz P; Chiodini V; Mangioni S; Orsi E; Fornari C; Mantovani LG
    PLoS One; 2014; 9(12):e113741. PubMed ID: 25470484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany.
    Kähm K; Laxy M; Schneider U; Rogowski WH; Lhachimi SK; Holle R
    Diabetes Care; 2018 May; 41(5):971-978. PubMed ID: 29348194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of treating type 2 diabetes (CODEIRE).
    Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
    Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
    Köster I; Hauner H; von Ferber L
    Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.